The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network-Reference-Cited by-同舟云学术

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

Published:2013-01-14 Issue:1 Volume:8 Page:e53745
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Voskens Caroline J.,Goldinger Simone M.,Loquai Carmen,Robert Caroline,Kaehler Katharina C.,Berking Carola,Bergmann Tanja,Bockmeyer Clemens L.,Eigentler Thomas,Fluck Michael,Garbe Claus,Gutzmer Ralf,Grabbe Stephan,Hauschild Axel,Hein Rüdiger,Hundorfean Gheorghe,Justich Armin,Keller Ullrich,Klein Christina,Mateus Christine,Mohr Peter,Paetzold Sylvie,Satzger Imke,Schadendorf Dirk,Schlaeppi Marc,Schuler Gerold,Schuler-Thurner Beatrice,Trefzer Uwe,Ulrich Jens,Vaubel Julia,von Moos Roger,Weder Patrik,Wilhelm Tabea,Göppner Daniela,Dummer Reinhard,Heinzerling Lucie M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients;FS Hodi;Proc Natl Acad Sci U S A,2003

2. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance;RH Friedline;J Exp Med,2009

3. CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma;PA Prieto;Clin Cancer Res,2012

4. Improved survival with ipilimumab in patients with metastatic melanoma;FS Hodi;N Engl J Med,2010

5. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;C Robert;N Engl J Med,2011

Cited by 425 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Photoprotection: Current developments and controversies;Journal of the European Academy of Dermatology and Venereology;2024-06-26

3. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

4. BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs;Molecules;2024-04-14

5. Delayed immune‐related adverse events in long‐responders of immunotherapy: a single‐center experience;Asia-Pacific Journal of Clinical Oncology;2024-04-12